Chapter 27: Macrolides & Advanced Antibiotic Classes

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Hello and welcome back to the lab.

It's great to be here.

If you are tuning in today, you are likely staring down a massive pharmacology exam.

Or maybe just realizing that antibiotic classes are a little more complicated than take two of these and call me in the morning.

Exactly.

Today, we are conducting a focused study session, you know, one designed specifically for nursing students who are tackling pharmacology.

And we are doing a deep dive into the source material from Chapter 27 of pharmacology, a patient -centered nursing process approach.

And let me tell you, Chapter 27 is a beast.

The title alone is a mouthful.

We're talking about macrolides, oxytocinones, lincosamides, glycopeptides, and lipopeptides.

It certainly sounds like a spelling bee list for medical professionals.

It really, really does.

But despite the tongue twisters, our mission today is to break this all down so it actually sticks.

And these are critical tools.

They're in the arsenal for fighting disease -producing microorganisms.

Right, we're talking bacteria, viruses, protozoans, fungi, I mean the whole lineup of pathogens.

Right.

And while the names are complex, the clinical reasoning behind them is I think pretty fascinating.

To set the stage, we really need to look at the big picture.

Okay.

Why are we even grouping these specific drugs together?

Good question.

Well, the primary thread connecting macrolides, oxytocinones, lincosamides, and glycopeptides is that they have spectrums of antibiotic effectiveness that are pretty similar to penicillin.

So these are your Plan B drugs, the substitutes.

In many cases, yes.

They are very often used as penicillin substitutes, particularly for patients who have a hypersensitivity or a severe allergy to penicillin.

Ah, okay.

So if you have a patient who goes into anaphylaxis with penicillin...

You're likely going to be reaching for something from this chapter, specifically a drug like erythromycin.

Okay, that's a great mental hook right there.

Penicillin allergy equals Chapter 27.

It's a good place to start.

Now, before we get into the specific drug classes, we need to clarify the mechanism.

Are we killing the bacteria or are we just asking them nicely to stop growing?

That is the classic distinction between bacteriostatic and bactericidal.

And most of the drugs we're discussing today, specifically the macrolides, oxytocinones, and lincosamides, are primarily bacteriostatic.

Bacteriostatic, meaning they inhibit growth.

Exactly.

They stop the bacteria from reproducing, which gives the body's own immune system a chance to come in and clean up the mess.

But there's a catch, right?

There's always a catch in pharmacology.

There is always a catch.

Depending on the drug dose, the serum level, and of course the specific pathogen you're fighting, they can actually become bactericidal.

So they can switch to actively killing the bacteria?

They can.

However, the last two groups we'll discuss, the glycopeptides and the lipopeptides, are strictly bactericidal.

So no gray area there?

No.

They are the heavy hitters.

They go in for the kill every time.

Got it.

So macrolides, oxytocinones, lincosamides are the inhibitors that can kill, and then glycopeptides and lipopeptides are just the killers.

Precisely.

A perfect way to frame it.

Alright, so here is our roadmap for this deep dive.

We're going to walk through each class one by one.

Starting with the macrolides.

Yes, the mysin group.

Then we'll move to the oxytocinones and lincosamides.

We're also going to spend some serious time on the nursing process, because that's what you really need for clinicals.

And finally, we will wrap up with the heavyweights, vancomycin and daptymycin, and then we'll pull it all together with a case study application.

Ready to get started?

I am ready.

Let's look at the macrolides.

Left unpack section one, macrolides.

You call them the mysin group.

They're broad spectrum antibiotics.

Who are the key players here?

The three main drugs you absolutely need to know in this class are erythromycin, clarithromycin, and azithromycin.

Okay.

Erythromycin is the original.

It was introduced way back in the early 1950s, and it was actually derived from a fungus -like bacteria called streptomyces erythris.

It's amazing how many of our best drugs come from, like, dirt or fungus.

It really is.

So how do these actually work?

What are they doing inside the bacteria?

They work by binding to the 50S ribosomal subunits.

The 50S subunit.

Okay, I remember that from microbiology.

And by binding there, they inhibit protein synthesis.

Bacteria, like any living thing, need to synthesize proteins to survive and to replicate.

So if you block that 50S subunit, you essentially shut down their factory.

And that's the bacteriostatic part.

Yes.

As we mentioned, at low to moderate doses, this effect is bacteriostatic.

It just pauses the production line.

But at high doses, it can become bactericidal.

And because they are broad spectrum, we can use them for a lot of different things.

Correct.

They are active against most gram -positive bacteria and also moderately active against some gram -negative bacteria.

So what would I see them prescribed for on a chart?

You'll see them prescribed for mild to moderate infections.

Things like respiratory tract infections, sinuses, the GI tract, and also skin or soft tissue infections.

Okay.

They're also used for diphtheria, impetigo contagiosa, and some sexually transmitted infections or STIs.

Now, you mentioned erythromycin as the original.

There are a couple of specific diseases where it's the absolute MVP, right?

The go -to drug.

Yes.

Absolutely.

Erythromycin is the drug of choice for treating mycoplasmal pneumonia and also Legionnaire's disease.

So if you see those on a chart or a test question, your brain should immediately go to erythromycin.

Immediately.

It's a key association to make.

Okay.

Let's shift gears a bit to pharmacokinetics.

So the movement of the drug through the body.

I remember reading there is a very specific problem with erythromycin in the stomach.

This is a crucial nursing consideration.

Gastric acid destroys erythromycin.

Just obliterates it.

Pretty much.

If you just swallowed pure erythromycin, the acid in your stomach would break it down before it ever got the chance to work.

It would be useless.

So how do we fix that?

How do we get it past the stomach?

The solution is chemistry.

We add acid -resistant salts, specifically ethyl succinate, stearate, or estylate to the drug formulation.

And these salts act like a shield.

Exactly.

These salts make the drug tough enough to survive the stomach acid so it can pass safely into the intestine, which is where it is actually absorbed.

And does food mess this up?

Should patients take it on an empty stomach?

Generally no.

With these acid -resistant salts, food usually doesn't hamper the absorption.

Now what about giving this IV?

I'm assuming we can give it intravenously if a patient can't take it orally?

You can give macrolides orally or by IV.

But here is a major, major safety alert from the text.

Okay.

You must never administer macrolides intramuscularly.

Not IM.

Why not?

What happens?

It is simply too painful for the patient.

It causes significant tissue irritation and pain.

So IM is completely off the table.

Okay, no IM.

Got it.

But even with IV, you have to be careful, right?

Extremely careful.

What's the risk with IV administration?

Phlebitis.

That is pain and inflammation in the vein at the infusion site.

And how do we present that?

To present phlebitis, 5e macrolides must be infused very slowly.

You cannot just push them quickly.

And you have to pay very close attention to the dilution instructions.

Can you give us the specifics on that dilution?

What should a nurse know?

Certainly.

For intermittent infusions, they need to be diluted in either normal saline NS or D5W, which is 5 % dextrose in water.

Okay.

And the volume matters.

For example, if you are giving erythromycin 500mg, it should be diluted in 250 -500mW of fluid.

That's a decent amount of fluid.

It is.

And if you're giving erythromycin, like, to bionate at 1g, that needs even more, 200 -1000mW of diluent.

So the takeaway is, lots of fluid, slow infusion.

That's the key to safety.

So how does the drug leave the body excretion?

It's primarily excreted through bile and feces.

Only a very small amount is actually excreted in the urine.

That sounds like a good thing for patients who have kidney issues.

It is.

It's a huge benefit.

Because renal excretion is so low, renal insufficiency is not a major contraindication for macrolide use.

The kidneys aren't doing the heavy lifting here, so they're generally safe in that population.

All right.

Let's talk about the bad stuff.

Side effects.

What is the patient most likely going to complain about?

The most common complaints are, without a doubt, going to be GI distress.

So nausea, vomiting?

Nausea, vomiting, diarrhea, and abdominal cramping are very, very common with macrolides.

Many patients experience some level of it.

And we aren't just talking about a little upset tummy here.

There is a specific, really dangerous type of diarrhea we need to be watching for.

Absolutely.

This is a critical point for all the drugs in this chapter, really, but especially for macrolides.

If a patient develops severe diarrhea, you must suspect CDD.

Which stands for?

Clostridium difficile associated diarrhea.

It's also known as pseudomembranous colitis.

And this is what we call a super infection, right?

The antibiotic causes another infection.

Yes.

That's exactly what it is.

The antibiotic kills off the normal, healthy gut flora that usually keeps everything in check.

Which creates an opening.

It does.

It allows the C.

diff bacteria to overgrow.

Then they release toxins that severely damage the colon lining.

What do the symptoms look like?

How would we recognize it?

The symptoms are pretty unmistakable.

Abdominal cramping and then 5 to 10 watery diarrheal stools per day.

Wow, 5 to 10.

And in severe cases, it could be up to 20 stools per day and they may even contain blood.

Yikes.

So if a patient on erythromycin says they have diarrhea, we do not just hand them an anti -diarrheal and walk away?

Never.

Absolutely not.

You need to investigate and rule out CDA first.

It's a serious complication.

Okay.

What about the liver?

Is there any risk there?

Yes.

Hepatotoxicity or liver toxicity is a risk.

When does that usually happen?

This usually happens when macrolides are taken in high doses concurrently with other hepatic toxic drugs.

So you're hitting the liver from multiple angles.

Like what other drugs are we talking about?

Think high -dose acetaminophen, phenothysines or sulfonamides.

The combination is what really increases the risk.

And the text mentioned a specific side effect for erythromycin involving the eyes.

It did.

Conjunctivitis can develop as a side effect.

It's important to teach patients to avoid wearing their contact lenses if this occurs.

Okay.

Good to know.

Let's move on to drug interactions.

I like to call this the increasers section.

That's a good way to remember it actually.

Macrolides can increase the serum levels of several other potent drugs.

And which drugs are we most concerned about?

Specifically, theophylline, which is a bronchodilator,

carbamazepine, an anticonvulsant, and warfarin, the anticoagulant.

And why is that so dangerous?

What's the risk of those serum levels going up?

Well, if the serum levels of those drugs go up, the patient can easily become toxic.

So for warfarin, that means a bleeding risk.

A severe bleeding risk.

For theophylline, if levels spike, you can get cardiac and CNS toxicity.

So the nursing implication here is strict monitoring of the serum levels of these other drugs.

Are there any drugs that erythromycin just shouldn't be in the same room with?

Yes.

Erythromycin should not be taken with clendamycin or lincomycin.

Why is that?

They actually compete for the same receptor sites on the bacteria.

So if you give them together, they can cancel each other out, or at least reduce the effectiveness of both.

Okay, so they fight over the same parking spot.

What about the heart?

There is a very serious cardiac risk noted in the text.

If you use erythromycin concurrently with certain other drugs, like verapamil, diltiazem, or antifungals, like fluconazole or ketoconazole, it significantly increases the risk of sudden cardiac death.

Sudden cardiac death, that is extreme.

It is.

It's thought to be due to the drug concentration spiking and affecting the heart's electrical rhythm.

It's a major interaction to be aware of.

One last interaction to note antacids.

Something as simple as Tums.

Even that.

Antacids can reduce the peak levels of azithromycin if you take them at the same time.

You need to space them out.

Alright, let's zoom in a little on the extended macrolides.

So chlorothromycin and azithromycin.

Why did we invent these if we already had erythromycin?

It really comes down to convenience and duration.

They have much longer half -lives.

And a longer half -life means less frequent dosing.

Exactly.

And compliance from patients always goes up when you don't have to take a pill four times a day.

Makes sense.

Let's look at chlorothromycin first.

Chlorothromycin is typically taken BDSO twice daily for the immediate release version, or just once daily for the extended release form.

And what's it used for?

It's commonly used to treat H.

pylori and peptic ulcer disease, as well as otitis media and various skin infections.

And then there is the star of the show, azithromycin.

Our book has a whole prototype drug chart for this one.

And for good reason.

Azithromycin is pretty unique because of its massive half -life.

It's 68 hours.

68 hours?

That is almost three full days.

Exactly.

And this is what allows for that convenient once -a -day dosing and often very short treatment courses like the five -day Z -Pak.

But the chart also notes that the bioavailability is only about 37%.

What does that mean?

That means only about 37 % of the oral dose actually reaches the systemic circulation to do its job.

The rest is lost along the way.

What are the big red flags or contraindications for azithromycin?

When should we be extra cautious?

You need to be very cautious with patients who have hypokalemia, which is low potassium, or hypomagnesemia, low magnesium.

Also anyone with birdycardia, a slow heart rate.

And the life -threatening reactions listed in the chart.

Those are hepatotoxicity, anaphylaxis, and Stevens -Johnson syndrome, which is that severe blistering skin reaction.

But again, hepatotoxicity is a major, major monitoring point.

Before we leave this section, there is one more drug mentioned in Table 27 .1, Fidaxomacin.

Right.

Fidaxomacin is a newer agent in this class.

What's its claim to fame?

Its claim to fame is that it's specifically used for treating CDD.

That's Clostridium difficile -associated diarrhea.

Wait, so there's a bit of irony there.

A lot of irony.

While other macrolides might cause C.

diff, Fidaxomacin is specifically used to treat it.

The beautiful paradox of pharmacology.

Okay, that's a great place to pause.

Next up, Section 2, Oxazolidinones.

Another mouthful of a name.

The key drugs to know here are Linazolid and Tetazolid.

And how do they work?

Is it similar to the macrolides?

It is similar.

They also inhibit protein synthesis on that 50S ribosomal subunit.

Okay.

But they do it in a slightly different way.

They prevent the formation of the 70S initiation complex, which is a necessary first step for bacterial reproduction.

So still bacteriostatic for the most part?

Primarily, yes.

And they are particularly effective against gram -positive infections.

And when do we pull these out of the cabinet?

Are they for everyday infection?

No, definitely not.

These are reserved for very serious stuff.

Like what?

Things like bacteremia, sepsis, and specifically for treating multidrug -resistant organisms.

So we're talking about the superbugs.

Exactly.

We're talking about MRSA, methicillin -resistant Staphylococcus aureus, and VREF, which is vancomycin -resistant, and terrococcus fascium.

So if you see VREF on a patient's chart, you should be thinking Linazolid might be on the table.

That's a key indication for it, yes.

What are the side effects we need to watch for?

The common ones are what you might expect.

Headache, nausea, diarrhea.

And the more serious ones?

The more serious ones include anemia and prompocytopenia.

Prompocytopenia, that's low platelets, so we have a bleeding risk.

A significant bleeding risk.

And of course, like with most broad spectrum antibiotics,

CDA is always a risk.

But there is a very specific, very dangerous interaction with this class that involves serotonin.

This is probably the most critical takeaway for oxazolid anones.

You have to be extremely careful about the risk of serotonin syndrome.

Okay, break that down for us.

What is that?

So Linazolid has properties that inhibit an enzyme called monoamine oxidase or MAO.

Right.

So if you combine Linazolid with actual MAO inhibitors, you can trigger a hypertensive crisis.

But the more common danger is combining it with SSRIs.

The common antidepressants?

Yes, selective serotonin reuptake inhibitors or tricyclic antidepressants or even certain pain medications like tramadol.

That combination can cause serotonin syndrome.

This is where the serotonin levels in the central nervous system get dangerously high.

Dangerously high.

And it can be fatal.

The source explicitly mentions that deaths have occurred from this interaction.

So as a nurse, before starting Linazolid, you absolutely must check the patient's medication list for antidepressants.

It's a stop -the -line moment.

You have to reconcile that medication list carefully.

Got it.

Okay, moving on to section three.

Lincosamides.

Here we have two drugs, clindamycin and lincomycin.

Which one do we use more often?

Clindamycin is much, much more widely prescribed.

And why is that?

It just has a better profile.

It has better absorption, it maintains higher serum concentrations, and it has fewer toxic effects compared to lincomycin.

So what does clindamycin kill?

What's its specialty?

It's active against most gram -positive organisms, including S.

aureus.

But its real superpower is that it is very effective against anaerobic organisms.

Anaerobic.

The ones that don't need oxygen.

Exactly.

And what does it not kill?

It is not effective against gram -negative bacteria like E.

coli or proteus.

Okay, let's talk side effects.

GI irritation is the big one.

Nausea, vomiting, and stomatitis, which is inflammation of the mouth and lips.

Anything else.

Rashes can occur.

But again, the severe adverse reactions to watch for are colitis and, of course, anaphylactic shock.

And are there any drugs that clindamycin doesn't play well with in an IV line?

Yes.

The text notes that it is incompatible with aminofalene, phenytoin, barbiturates, and ampicillin.

You would not want to mix these in the same IV line or bag.

Okay, good to know.

We've covered a lot of drugs now.

Let's bring this back to the bedside.

Section 4, clinical judgment and the nursing process.

We'll focus on the macrolides here, specifically azithromycin as our example.

Right.

Let's start with assessment.

In the nursing process, this is where you're recognizing cues.

So what are we looking for?

You need to check vital signs and urine output as a baseline.

And labs.

What labs are critical here?

Absolutely labs.

You must monitor liver enzymes, ALP, ALT, AST, and bilirubin.

This is crucial, especially if the patient is on large doses of azithromycin for a prolonged period.

And you're looking for any signs of liver dysfunction, like jaundice.

Exactly.

What about the patient's history?

You need to check for those interacting drugs we mentioned earlier, warfarin, theafiline, carbamazamine.

And you need to ask if they are taking any antacids.

Okay, moving from assessment to interventions.

What is the absolute golden rule before starting any antibiotic therapy?

Culture first.

Yeah.

Always.

You obtain a sample from the infected area for culture and sensitivity, or CNS, before you administer the first dose.

Why is that order so important?

If you give the antibiotic first, you might kill off the bug in the sample, and then you'll never know for sure what you were treating or if you picked the right drug to treat it with.

Now, timing matters for oral azithromycin.

What's the rule there?

The general rule is to administer oral azithromycin one hour before or two hours after meals.

So, an empty stomach is preferred?

It is, for best absorption.

However, the text does note that if GI upset becomes a big problem, you can give it with food.

And what should they take it with?

Give it with a full glass of water.

Not fruit juice, as that can affect absorption.

Just plain water.

What if they have the chewable tablets?

The instruction is clear.

They must be chewed.

They should not be swallowed whole.

And if the patient really needs that antacid for their heartburn?

You have to space it out.

Give the antacid either two hours before or two hours after the azithromycin.

Never give them together.

Okay.

Finally, patient teaching.

What are the key things we need to tell them before they go home?

First and foremost is compliance.

They have to take the full course of the antibiotic.

Don't stop just because you feel better on day three.

Exactly.

Second, they need to know what to report.

Specifically, report any loose stools or diarrhea immediately so we can rule out C.

diff.

And what else?

They should also watch for signs of a super infection.

Things like stomatitis, you know, sores or white patches in the mouth, or vaginitis, which could present as itching or discharge.

Excellent.

That's a great practical summary.

Now let's move to the heavy hitters.

Section five, glycopeptides.

And the undisputed star of this group is vancomycin.

Vank, the big gun.

It's the one everyone's heard of.

It's been used since the 1950s and it is a bactericidal drug.

It kills bacteria.

And what do we primarily use it for now?

Its main use today is for treating drug resistant S.

aureus.

MRSA?

MRSA, yes.

And it's also used for cardiac surgical prophylaxis in patients who have a severe allergy to penicillin.

But it's not a perfect drug, is it?

Has it lost some of its power?

It has.

The text specifically notes that it has become ineffective for treating enterococci, which has led to the rise of VREF vancomycin resistant enterococci.

Now, the pharmacokinetics for vancomycin are tricky because the route of administration really, really matters.

Let's talk about oral vancomycin versus 5e vancomycin.

Oh, this is a concept that students often struggle with, but it's critically important.

Oral vancomycin is not absorbed systemically.

What do you mean by that?

I mean, it goes in the mouth and it stays in the gut.

It's not absorbed into the bloodstream.

It just passes through the GI tract and is excreted in the feces.

So why would we ever give it orally if it doesn't get into the blood?

You give it orally to treat infections that are inside the gut.

Ah, so it works locally.

Exactly.

Oral vancomycin is used only for treating clostridium difficile, CDA, and staphylococcal enterocolitis.

Okay, so if a patient has MRSA in their blood septicemia and you give them oral vancomycin.

It will do absolutely nothing for the septicemia.

It won't reach the blood.

Eww, for systemic infections.

For septicemia, for bone infections or skin infections, you must use intravenous for vancomycin.

4 -vene -Bank gets into the bloodstream, is excreted in the urine, has a protein binding of about 55%, and a half -life of 4 -6 hours.

Okay, so let's talk about giving it RFID.

This seems like a high -stakes administration.

It is.

There are very strict rules.

First, you have to delete it properly.

The standard is 500mg in 100ml of fluid or 1g in 200ml.

And what's the most critical factor?

The rate.

The infusion rate is everything.

You must administer vancomycin over 60 -90 minutes.

Never faster.

Why so slow?

What happens if you run it in too fast?

You can cause vancomycin flushing syndrome.

It used to be called red man syndrome.

Okay, let's unpack that.

What does it actually look like?

The patient develops this very dramatic red flushing of the face, neck, chest, and their upper body.

It can look very scary.

And are there other symptoms?

Yes.

They might also have significant hypotension, a big drop in blood pressure and tachycardia.

So, is this an allergic reaction?

No.

And that is the absolute key point to understand.

It is a toxic effect caused by infusing the drug too fast.

It is not a true allergy.

So if this happens, we don't administer epinephrine and call a code blue?

No, you do not.

The first thing you do is slow the rate down, slow the infusion to 10 mg per minute or less, or just stop it temporarily until the symptoms subside.

And they usually do subside?

Yes.

The symptoms usually resolve in about 20 minutes once you stop the infusion.

It is a rate -dependent reaction.

Got it.

Aside from the flushing, vancomycin has some other pretty serious toxicities.

It does.

The two big ones are nephrotoxicity, which is kidney damage, and ototoxicity, which is ear damage.

Ototoxicity affects cranial nerve A8, the auditory nerve.

Correct.

And this isn't temporary.

It can result in permanent hearing loss or permanent loss of balance.

And does the risk go up if they're taking other drugs?

It does.

The risk increases if the patient is also taking other ototoxic drugs,

like lupediretix furosemide is a common one, or aminoglycosides.

The text also warns that dimonhydrinate, or Dremamine, can mask the early signs.

Yes, it can hide the initial dizziness or tinnitus, making it harder to detect the ototoxicity early.

And with nephrotoxicity, that means we are watching those kidney labs like a hawk.

BUN and creatinine, absolutely.

You have to monitor them closely throughout therapy.

Are there newer glycopeptides that try to improve on vancomycin?

There are.

The book mentions televansin, which is a derivative of vancomycin that allows for once -daily dosing, but it has a weird side effect of causing a metallic taste.

And then there's ordivansin, which is really interesting because it can be given as a single dose, and it has a massive half -life of 245 hours.

245 hours.

That is over 10 days.

It stays in the system for a very long time.

Wow.

Okay, moving to our final class, section six, the lipopeptides.

And the main drug to know here is daptomycin.

How does daptomycin kill bacteria?

What's its mechanism?

It has a really cool mechanism.

It binds to the bacterial membrane and causes a rapid depolarization of the membrane potential.

It sounds like it electrocutes the cell.

That's a great way to think about it.

It basically zaps the cell wall, which then inhibits protein, DNA, and RNA synthesis.

Cell death follows very quickly.

And what is it used for?

It's used for complicated skin infections caused by gram -positive bacteria, septicemia involving S.

aureus, and endocarditis, specifically MRSA endocarditis.

The text has a very specific instruction on how to mix this drug for IV use.

Yes, and it's unique.

You dilute the 500 -milligram vial with normal saline.

Then, and this is the odd part, you have to let it stand for 10 minutes.

Just let it sit.

Just let it sit.

And then after 10 minutes, you rotate it gently.

The instruction is very clear.

Do not shake it.

Why no shaking?

What happens?

It foams up excessively if you shake it, which you don't want in an IV medication.

You have to be gentle with it.

And another key point about mixing.

Do not mix it with dextrose -containing diluents.

It's only compatible with normal saline.

Okay.

What are the side effects of Daptomycin?

It can cause hypertension, or hypotension, and insomnia.

But the really serious one you need to know is rhabdomyolysis.

Rhabdo.

That's muscle breakdown, right?

Yes.

A serious breakdown of muscle tissue.

It can lead to elevated CPK levels, creatine phosphokinase, and potentially severe kidney damage.

And because of this specific muscle risk, there is a major drug interaction we need to watch for.

Statins.

The cholesterol -lowering drugs like synvastatin.

Because they can also cause muscle issues.

Exactly.

Since statins can also cause rhabdomyolysis, taking them with Daptomycin significantly increases that risk.

You also need to watch warfarin, as the bleeding risk can increase.

All right.

We have covered a massive amount of content.

Now let's try to apply it.

Section 7.

Review and application.

We have a clinical judgment case study.

Let's look at it.

The scenario is, a 54 -year -old male with chronic bronchitis is prescribed clarithromycin 250 mg every 12 hours.

Okay.

Question 1.

Is this dose normal and appropriate?

Looking at the data in the chapter, yes it is.

For immediate release clarithromycin, the standard adult dose is 250 mg q12 hours every 12 hours for 7 to 14 days.

So the order is perfectly appropriate.

Good.

Question 2.

What side effects should the nurse teach this patient about?

What should he expect?

Based on the common profile for clarithromycin,

the nurse should definitely warn him about nausea, diarrhea, and headache.

And there's that taste one, right?

Yes.

Dysjucio, which is a distortion of the sense of taste, and also dyspepsia or indigestion.

And question 3.

What are the serious adverse effects that he needs to report immediately if they happen?

He needs to know to report any signs of a super infection, like white patches in his mouth,

also any symptoms of hepatoxicity like yellowing of his skin or eyes, and of course any severe diarrhea, which could indicate CDA.

Perfect.

Let's run through a few quickfire viewpoints based on the chapter questions just to solidify these concepts.

Go for it.

You have a patient on daptomycin.

What are the key nursing protocols for administration?

Okay, daptomycin.

Delute it in normal saline, not dextrose.

Administer the CNV over 30 minutes.

And monitor for any muscle pain or weakness, which could be a sign of rhabdomyolysis.

Good.

Next one.

You have a patient on azithromycin.

What are your key nursing actions?

For azithromycin, I'm going to monitor their liver function tests.

I'm going to tell them to report any loose stools immediately.

And I'm going to teach them to take it one hour before or two hours after meals and to avoid taking antacids close to their dose.

Excellent.

Patient on clindamycin, that's a lincosamide.

What is the big scary adverse effect we are most worried about?

With clindamycin, the number one thing to monitor for is clostridium difficile associated diarrhea, CDE.

You have to monitor their stool frequency and consistency very closely.

Okay, last one.

The classic nursing school scenario.

You're giving vancomycin the five, the patient's face and neck turn bright red, and their BP drops to 70 over 50.

What do you do?

This is vancomycin flushing syndrome.

The first action is to stop the infusion.

Stop it completely.

Stop it.

Do not just encourage fluids or treat it as an allergy or Stevens -Johnson syndrome initially.

The immediate action is to stop the infusion.

Once the symptoms resolve, you can contact the provider about restarting it at a much slower rate, like 10 milligrams per minute or less.

But the first move is always to stop the infusion.

Perfect.

This has been quite a journey.

It really has.

We started with the macrolides erythromycin and its friends as the primary penicillin substitutes.

We navigated the issues with stomach acid and the serious liver risks.

We did.

Then we moved through the oxazalidinones and that critical danger of serotonin syndrome.

We also touched on the lincosamides and the important anaerobic coverage of clindamycin.

And we finished strong with the heavy bactericidal agents.

Vancomycin with its flushing syndrome and autotoxicity and daptomycin with its very specific mixing rules and muscle risks.

You know, for me, the biggest takeaway from this whole chapter is the nurse's central role in safety.

How so?

It isn't just about giving the drug.

It's about knowing how to administer it, slowly diluted correctly.

And it's about what to watch for the diarrhea, the liver enzymes, any hearing loss.

Absolutely.

It's about protecting the kidneys, protecting the ears and protecting the gut.

Right.

And here is a provocative thought to leave you with as you study.

Vancomycin, as we said, used to be the silver bullet for resistant staph.

But now the text explicitly states that it's ineffective for VREF vancomycin resistant enterococci.

So we've already seen resistance developed to one of our best drugs.

Exactly.

And now we're relying on these other powerful substitutes like lenazolid and daptomycin.

So the question is, as we use these, how long will it be until we start seeing widespread resistance there?

And what is the nurse's role in antibiotic stewardship to help prevent that?

That's a great point.

It's not just about giving meds.

It highlights that the nurse's role isn't just administration.

It's stewardship.

Using these powerful drugs only when absolutely necessary and, importantly, ensuring patients complete their full courses of therapy is vital to preserving these tools for the future.

That is a sobering but very important thought.

The war against these pathogens is constantly evolving.

And as a nurse, you are right there on the front lines.

Study hard and stay safe in practice.

Thanks for diving deep with the Last Minute Lecture Team.